» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-2 of 2 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: Effects of cardamom supplementation on anheropometric indices, cardiometabolic status, obesity and diabetes gene expression among obese women with polycystic ovary syndrome Design: The double blind randomized clinical trial will be performed on 140 women with polycystic ovary syndrome with a body mass index more than 30. Settings and conduct: This study will be performed on 140 women with polycystic ovary syndrome referred to Motazedi Educational and Medical Center- Kermanshah during 12 weeks. The intervention group will receive 3 grams of cardamom supplement daily. Before and after the intervention of food intake, physical activity, as well as blood pressure, biochemical indices, lipid profile, sexual hormones, obesity and diabetes genes will be taken from the participants. Participants/Inclusion and exclusion criteria: Inclusion criteria: Diagnosis of polycystic ovary syndrome based on Rotterdam criteria in 18- 45-year-old volunteer women with a body mass index more than 30 kg/ m2 Exclusion criteria: pregnancy, lactation, diseases such as autoimmune, gastrointestinal, liver, thyroid and unstable cardiovascular diseases, severe depression, mental and psychological illness, severe respiratory diseases (asthma and chronic bronchitis), consumption of any vitamin and mineral supplements, allergies to cardamom, cardamom tea and cardamom products Intervention groups: All participants will be subjected to a weight loss diet, in which case they will lose 500-300 kcal per day of energy required based on the ideal adjusted body weight. Intervention group: 3 grams of cardamom in three doses of one gram with the main meals to reduce possible gastrointestinal complications Control group: Plasbo with the same appearance of intervention supplements and the same hours of consumption Main outcome variables: Anthropometric and cardio-metabolic indices, obesity and diabetes gene
IRCTID: IRCT20200608047697N1
  1. Clinical trial of the effect of Q10 supplementation compared with the placebo on levels of gene expression related with glycemic control and inflammatory factors in women with polycystic ovary syndrome
  2. Clinical trial of the effect of combined chromium and carnitine supplementation on metabolic profiles and gene expression related to insulin and lipid in women with polycystic ovary syndrome
  3. Clinical trial of the effect of chromium supplementation compared with the placebo on gene expression related to insulin and lipid in women with polycystic ovary syndrome candidate for IVF
  4. The effect of vitamin D supplementation on anthropometric indices and androgen hormones in women with polycystic ovary syndrome treated with low calorie diet
  5. Clinical trial of the effect of selenium supplementation compared with the placebo on gene expression related to inflammation in women with polycystic ovary syndrome candidate for IVF.
  6. The effect of Q10 supplementation on metabolic profiles and gene expression related to insulin and lipid in women with polycystic ovary syndrome candidates for IVF
  7. The effect of curcumin supplementation on metabolic profiles and gene expression related to insulin and lipid in women with polycystic ovary syndrome
  8. Clinical trial of the effect of melatonin supplementation compared with the placebo on hormonal profiles, inflammatory factors, oxidative stress biomarkers and gene expression related to inflammation in women with polycystic ovary syndrome
  9. Clinical trial of the effect of vitamin D supplementation compared with the placebo on metabolic profiles and gene expression related to insulin and lipid in women with polycystic ovary syndrome candidate for IVF
  10. Effect of spirulina (Arthrospira plantensis) supplementation on nutritional status, hormonal status, cardiometabolic indices and clinical symptoms in women with polycystic ovary syndrome
Study aim: The effect of anti-inflammatory diets, low carbohydrate portfolio and intermittent fasting on cardiometabolic status and gene expression Design: The clinical trial has a control group with randomized and open label on 100 patients with pre-diabetes, which will be used for randomization from the table of random numbers. Settings and conduct: In order to carry out the present study, by examining the files of patients referred to the central laboratory of Kermanshah University of Medical Sciences, patients who meet the conditions to enter the study will be invited to the laboratory of the School of Nutritional Sciences and Food Technology Participants/Inclusion and exclusion criteria: A total 100 patients with pre-diabetes will be invited according to ADA criteria, aged 18-55 years and BMI ≥25 kg/m2, who consented to participate in the study. Conditions for not including to the study as follow: pregnancy, lactation, suffering from diseases such as autoimmune diseases, thyroid and unstable cardiovascular diseases, diabetes, severe depression (due to the inability to answer the questions) ), mental and mental illnesses, and finally medication use related to the above conditions. patients who refuse to cooperate during the intervention, patients who become unavailable due to migration or any other reason, women who become pregnant during the intervention will be excluded from the study. Intervention groups: Participants were randomly divided into 4 groups: 1) calorie restriction (control) (n=25), 2) low carbohydrate portfolio diet group (n=25), 3) intermittent fasting group (n=25) and 4) group anti-inflammatory diet (n=25) will be divided. Main outcome variables: Improving glycemic indices and related gene expression including insulin Receptor (INSR), transcription factor 7 like 2 (TCF7L2), PPARG Co-activator 1- α (PGC1-a)
IRCTID: IRCT20200608047697N2
  1. Investigation of TCF7L2 gene expression following aerobic exercise with and without blood occlusion in white blood cells of type 2 diabetes patients
  2. Comparison of the effect of portfolio low-carbohydrate diet and the ketogenic diet on anthropometric indices, hormonal and lipid profiles in overweight or obese women with polycystic ovary syndrome
  3. Clinical trial of the effect of probiotic supplementation compared with the placebo on gene expression related to inflammation, insulin and lipid in patients with Parkinson's disease
  4. Clinical trial of the effect of Q10 supplementation compared with the placebo on levels of gene expression related with glycemic control and inflammatory factors in women with polycystic ovary syndrome
  5. The effects of omega-3 supplementation on inflammatory factors, oxidative stress biomarkers, pregnancy outcomes, and gene expression related to insulin, lipid, and inflammation in women with gestational diabetes
  6. Investigating the effect of Bane (Pistacia atlantica sub. Kurdica) gum oral supplement on the improvement of oxidant/ antioxidant and inflammatory indices, and Keap1/Nrf-2/ARE signaling pathway in patients with non-alcoholic fatty liver disease: A Randomized Clinical Trial
  7. The effects of vitamin D supplementation compared with the placebo on gene expression related to insulin and lipid in diabetic hemodialysis patients
  8. The effect of curcumin supplementation on glycemic control, antioxidant and anthropomethric indices, PGC1-α and SIRT1 gene expression in polycystic ovary syndrome(PCOS) women
  9. Comparison of the effect of intensive lifestyle intervention including two diets, calorie-carbohydrate restricted diet and the time restricted feeding on glycemic biomarkers, eating disorders, and appetite, in overweight and obese type 2 diabetic patients: a randomized controlled trial study
  10. Investigation of Metformin effect on the expression of H19, MEG3, MALAT1 and GAS5 long non-coding RNA levels in patients with type 2 diabetes: a clinical trial study
Loading...